Arthur C. Butcher's Form 4 Filing: Restricted Stock Units Vesting and Stock Sale

This Form 4 filing reports transactions by Arthur C. Butcher, EVP & Group President of MedSurg & APAC at Boston Scientific Corp. On May 2, 2026, Butcher had 2,102 restricted stock units vest and convert to common stock at $0 per share (transaction code M). On the same day, he sold 1,007 shares of common stock at $56.50 per share (transaction code F). Following these transactions, Butcher directly owns 56,887 shares and indirectly holds 20,228 shares through the company's 401(k) plan. The restricted stock units were granted with a four-year vesting schedule beginning May 2, 2023. These transactions represent routine equity compensation activity and portfolio management by a senior executive.